Longevity Global Community Pitch
Attend this online event to hear about projects in the Longevity Global Community. Longevity Global is a non-profit. We host events for our curated community of longevity researchers, investors, and entrepreneurs. These monthly events include research talks, networking events, hikes, and our annual finale event, the Longevity Summit at the Buck Institute for Research on Aging. We also connect virtually on Slack. You can apply to join us here.
At this event there will be three 10 minute presentations followed by questions from the audience. Presentations can be startup pitches or projects that people are working on. Folks presenting should feel free to make any asks they may have, from funding, to hiring, finding teammates, or resources.
Companies speaking:
1. David Scieszka of Eterna Biotechnology
Eterna Biotechnology is developing virus-like particle (VLP) vaccines to target senescence and extend healthy lifespan. Our overarching goal is to provide accessible and affordable longevity solutions for all. The lead program is a VLP vaccine targeting senescence to provide protection against pelvic organ prolapse, cardiovascular disease, and pulmonary dysfunction, which has the added benefit of lifespan extension. Preclinical mouse data shows the vaccine can significantly extend lifespan and improve organ function. We are proposing further preclinical studies in disease models to support clinical development. The estimated peak yearly revenue is $81B across multiple indications, with a long-term valuation potential over $1T. We are requesting $1.5M to fund CRO studies and advance the program over 3 years.
2. Jáchym Fibír of April19 Discovery
April19 is a drug development company integrating AI with computational chemistry to design and develop the next generation of psychedelic-inspired compounds. By optimizing psychedelics with a unique pharmacology identified in academic research, April19 seeks to expand the utility of psychedelics beyond mental health into neurodegenerative indications and healthy longevity.
3. Silvia Veronese of GTCardio
At GTcardio our goal is to provide every person with the knowledge of their cardiovascular health every second of their life. We are focused on developing technologies to optimize total wellbeing, improve longevity and prevent cardiovascular diseases. We do it by solving the problem of hypertension, by continuous hemodynamic monitoring, and assessing for personalized and optimal treatment to reduce vascular age.
The presentations slots are full for this event. If you would like to pitch at the next event, you can apply by filling out this short form: https://forms.gle/g92XwVmUsaGKyYB49. All stages of projects are welcome. You must be a Longevity Global member to pitch. You can apply to join us here.
Follow us on the platform formerly know as Twitter @LongevityGL